The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Utility of a novel quantitative EGFR-mutated protein analysis using AQUA system for EGFR-TKI treatment in non-small cell lung cancer.
Koichi Goto
Consultant or Advisory Role - Advisory Role
Honoraria - Seminar presentations
Genichiro Ishii
No relevant relationships to disclose
Kaori Fujimoto-Ouchi
No relevant relationships to disclose
Masatoshi Shirane
No relevant relationships to disclose
Tatsuro Saito
No relevant relationships to disclose
Morie Nishiwaki
No relevant relationships to disclose
Hironobu Ohmatsu
No relevant relationships to disclose
Seiji Niho
No relevant relationships to disclose
Kiyotaka Yoh
No relevant relationships to disclose
Shigeki Umemura
No relevant relationships to disclose
Yuki Yamane
No relevant relationships to disclose
Toshihiro Shiozawa
No relevant relationships to disclose
Yoko Yamaguchi
No relevant relationships to disclose
Tetsuhiko Taira
No relevant relationships to disclose
Kanji Nagai
No relevant relationships to disclose
Yuichiro Ohe
No relevant relationships to disclose